Hyperprogressive disease in lung metastases without target lesion progression after durvalumab consolidation therapy: A case report

Abstract Hyperprogressive disease (HPD) is a novel progressive pattern that occurs after immune checkpoint inhibitor (ICI) administration. Here, a 74‐year‐old woman who had undergone right lower lobectomy for lung cancer received curative chemoradiotherapy followed by consolidation therapy with durv...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Kosuke Masuda, Yoshiaki Nagai, Hikari Amari, Hiroki Tahara, Yuki Maeda, Jun Shiihara, Hiromitsu Ohta, Masahiro Hiruta, Yasuhiro Yamaguchi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2023-11-01
Colecção:	Thoracic Cancer
Assuntos:	hyperprogressive disease immune checkpoint inhibitor lung cancer
Acesso em linha:	https://doi.org/10.1111/1759-7714.15104
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!